octopamine and Bone Loss, Osteoclastic
octopamine has been researched along with Bone Loss, Osteoclastic in 1 studies
Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Sherman, BE | 1 |
Chole, RA | 1 |
Other Studies
1 other study available for octopamine and Bone Loss, Osteoclastic
Article | Year |
---|---|
Effects of catecholamines on calvarial bone resorption in vitro.
Topics: Animals; Animals, Newborn; Bone Remodeling; Bone Resorption; Calcium; Cells, Cultured; Dose-Response | 2001 |